{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:04:42Z","timestamp":1789873482317,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG083039"],"award-info":[{"award-number":["R01AG083039"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11606-025-09433-6","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:34:25Z","timestamp":1740483265000},"page":"3128-3136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Racial Inequality in Receipt of Medications for Opioid Use Disorder in Nationwide Outpatient Settings\u2014A Cross-sectional Study"],"prefix":"10.1007","volume":"40","author":[{"given":"Jingna","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sori K.","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelhameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-6152","authenticated-orcid":false,"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"9433_CR1","unstructured":"Ahmad FB, et al. Provisional drug overdose death counts. National Center for Health Statistics. 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm.\u00a0Accessed Nov 2023"},{"key":"9433_CR2","doi-asserted-by":"crossref","unstructured":"Mutter R, Spencer D, McPheeters J. outcomes associated with treatment with and without medications for opioid use disorder. J Behav Health Serv Res. 2023;50(4):524-539.","DOI":"10.1007\/s11414-023-09841-8"},{"key":"9433_CR3","doi-asserted-by":"crossref","unstructured":"Sordo L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","DOI":"10.1136\/bmj.j1550"},{"key":"9433_CR4","doi-asserted-by":"crossref","unstructured":"Perry A, et al. Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic. Drug Alcohol Depend. 2023;253:111023.","DOI":"10.1016\/j.drugalcdep.2023.111023"},{"key":"9433_CR5","doi-asserted-by":"crossref","unstructured":"Marotta PL, et al. Racial and ethnic disparities, referral source and attrition from outpatient substance use disorder treatment among adolescents in the United States. Youth Soc. 2022;54(1):148-173.","DOI":"10.1177\/0044118X20960635"},{"key":"9433_CR6","doi-asserted-by":"crossref","unstructured":"Barnett ML, et al. Racial inequality in receipt of medications for opioid use disorder. N Engl J Med. 2023;388(19):1779-1789.","DOI":"10.1056\/NEJMsa2212412"},{"key":"9433_CR7","doi-asserted-by":"crossref","unstructured":"Mennis J, Stahler GJ. Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances. J Subst Abuse Treat. 2016;63:25-33.","DOI":"10.1016\/j.jsat.2015.12.007"},{"key":"9433_CR8","doi-asserted-by":"crossref","unstructured":"Krawczyk N, et al. Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. J Subst Abuse Treat. 2021;126:108329.","DOI":"10.1016\/j.jsat.2021.108329"},{"key":"9433_CR9","doi-asserted-by":"crossref","unstructured":"Entress RM. The intersection of race and opioid use disorder treatment: A quantitative analysis. J Subst Abuse Treat. 2021;131:108589.","DOI":"10.1016\/j.jsat.2021.108589"},{"key":"9433_CR10","doi-asserted-by":"crossref","unstructured":"Mattick RP, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;2014(2):CD002207.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"9433_CR11","doi-asserted-by":"crossref","unstructured":"Mattick RP, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;2009(3):CD002209.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"9433_CR12","doi-asserted-by":"crossref","unstructured":"Lee JD, et al. Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. N Engl J Med. 2016;374(13):1232-42.","DOI":"10.1056\/NEJMoa1505409"},{"key":"9433_CR13","doi-asserted-by":"crossref","unstructured":"Watts BV, et al. Association of medication treatment for opioid use disorder with suicide mortality. Am J Psychiatry. 2022;179(4):298-304.","DOI":"10.1176\/appi.ajp.2021.21070700"},{"key":"9433_CR14","doi-asserted-by":"crossref","unstructured":"Voss RW, et al. Comparing ascertainment of chronic condition status with problem lists versus encounter diagnoses from electronic health records. J Am Med Inform Assoc. 2022;29(5):770-778.","DOI":"10.1093\/jamia\/ocac016"},{"key":"9433_CR15","doi-asserted-by":"crossref","unstructured":"Gorina Y, Kramarow EA. Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm. Health Serv Res. 2011;46(5):1610-27.","DOI":"10.1111\/j.1475-6773.2011.01277.x"},{"key":"9433_CR16","doi-asserted-by":"crossref","unstructured":"Williams AR, et al. Corrigendum to \"Developing an opioid use disorder treatment cascade: a review of quality measures\" [Journal of Substance Abuse Treatment 91 (2018) 57-68]. J Subst Abuse Treat. 2018;92:99.","DOI":"10.1016\/j.jsat.2018.06.015"},{"key":"9433_CR17","doi-asserted-by":"crossref","unstructured":"Williams AR, et al. Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder. Am J Psychiatry. 2020;177(2):117-124.","DOI":"10.1176\/appi.ajp.2019.19060612"},{"key":"9433_CR18","doi-asserted-by":"crossref","unstructured":"Lagisetty PA, et al. Buprenorphine treatment divide by race\/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979-981.","DOI":"10.1001\/jamapsychiatry.2019.0876"},{"key":"9433_CR19","doi-asserted-by":"crossref","unstructured":"Andraka-Christou B. Addressing racial and ethnic disparities in the use of medications for opioid use disorder. Health Aff (Millwood). 2021;40(6):920-927.","DOI":"10.1377\/hlthaff.2020.02261"},{"key":"9433_CR20","doi-asserted-by":"crossref","unstructured":"Mark TL, et al. Improving research on racial disparities in access to medications to treat opioid use disorders. J Addict Med. 2023;17(3):249-257.","DOI":"10.1097\/ADM.0000000000001104"},{"key":"9433_CR21","doi-asserted-by":"crossref","unstructured":"Stahler GJ, Mennis J, Baron DA. Racial\/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US. Drug Alcohol Depend. 2021;226:108849.","DOI":"10.1016\/j.drugalcdep.2021.108849"},{"key":"9433_CR22","doi-asserted-by":"crossref","unstructured":"Hollander MAG, et al. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use. Drug Alcohol Depend. 2021;227:108927.","DOI":"10.1016\/j.drugalcdep.2021.108927"},{"key":"9433_CR23","unstructured":"Public Law 115-271, Support for patients and communities Act,  132 STAT. 3894, 2018. https:\/\/www.congress.gov\/bill\/115th-congress\/house-bill\/6\/text"},{"key":"9433_CR24","doi-asserted-by":"crossref","unstructured":"Cruz FA, Jegede O. Addressing racial and ethnic inequities in opioid overdose mortality: strategies for equitable interventions and structural change. Curr Psychiatry Rep. 2024;26(12):852-858.","DOI":"10.1007\/s11920-024-01556-7"},{"key":"9433_CR25","unstructured":"O\u2019Neill Institute for National and Global Health Law. 2023 state legislation addiction policy update. Georgetown University Law Center. 2023, October 4.  https:\/\/oneill.law.georgetown.edu\/publications\/2023-state-legislation-addiction-policy-update\/"},{"key":"9433_CR26","unstructured":"Schwartz M. Obstacles and Advances to Accessing Medication for Opioid Use Disorder. Bill of Health, Petrie-Flom Center, Harvard Law School; 2020."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09433-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:04:29Z","timestamp":1771981469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09433-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9433"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09433-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"We declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}